Story thread · 4 reports / 4 sources
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
statnews.com · 3h · first report
How the coverage leans
Across 4 sources · syndicated copies counted once
A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.
The coverage
- FDA approves Regeneron’s garetosmab for disease that turns tissue to bone
endpts.com · 1h
- FDA approves Regeneron’s Pasatru for rare bone disorder FOP
investing.com · 2h
- Regeneron wins FDA nod for rare bone disorder therapy
seekingalpha.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.